Cargando…

The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan

COVID-19 is still the biggest issue worldwide. Many dietary supplements on the market claim to have anti-COVID-19 effects without scientific evidence. To elucidate the prevalence of dietary supplement usage for the prevention of COVID-19, we conducted an online cross-sectional questionnaire survey a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiba, Tsuyoshi, Tanemura, Nanae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370294/
https://www.ncbi.nlm.nih.gov/pubmed/35956391
http://dx.doi.org/10.3390/nu14153215
_version_ 1784766750060969984
author Chiba, Tsuyoshi
Tanemura, Nanae
author_facet Chiba, Tsuyoshi
Tanemura, Nanae
author_sort Chiba, Tsuyoshi
collection PubMed
description COVID-19 is still the biggest issue worldwide. Many dietary supplements on the market claim to have anti-COVID-19 effects without scientific evidence. To elucidate the prevalence of dietary supplement usage for the prevention of COVID-19, we conducted an online cross-sectional questionnaire survey among Japanese adults in January 2022. The prevalence of dietary supplement use for the prevention of COVID-19 was 8.3%, and there was no gender difference. We also conducted additional research on these dietary supplement users (1000 males and 1000 females). The most popular ingredient used was vitamin C (61.0%), with vitamin D (34.9%) and probiotics (33.4%) following. Half of these participants reported using supplements for more than one year. The information sources that reportedly led them to start using dietary supplements for the prevention of COVID-19 were the Internet (44.0%), television and radio (29.9%), and family or friends (26.0%), and these information sources differed among generations. In conclusion, some of the population used vitamin/mineral supplements for the prevention of COVID-19 that might be beneficial for their health, but some used ingredients with no scientifically proven effects against the virus at this time. Therefore, information-based scientific evidence is important to prevent the inappropriate use of dietary supplements by consumers.
format Online
Article
Text
id pubmed-9370294
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93702942022-08-12 The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan Chiba, Tsuyoshi Tanemura, Nanae Nutrients Article COVID-19 is still the biggest issue worldwide. Many dietary supplements on the market claim to have anti-COVID-19 effects without scientific evidence. To elucidate the prevalence of dietary supplement usage for the prevention of COVID-19, we conducted an online cross-sectional questionnaire survey among Japanese adults in January 2022. The prevalence of dietary supplement use for the prevention of COVID-19 was 8.3%, and there was no gender difference. We also conducted additional research on these dietary supplement users (1000 males and 1000 females). The most popular ingredient used was vitamin C (61.0%), with vitamin D (34.9%) and probiotics (33.4%) following. Half of these participants reported using supplements for more than one year. The information sources that reportedly led them to start using dietary supplements for the prevention of COVID-19 were the Internet (44.0%), television and radio (29.9%), and family or friends (26.0%), and these information sources differed among generations. In conclusion, some of the population used vitamin/mineral supplements for the prevention of COVID-19 that might be beneficial for their health, but some used ingredients with no scientifically proven effects against the virus at this time. Therefore, information-based scientific evidence is important to prevent the inappropriate use of dietary supplements by consumers. MDPI 2022-08-05 /pmc/articles/PMC9370294/ /pubmed/35956391 http://dx.doi.org/10.3390/nu14153215 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chiba, Tsuyoshi
Tanemura, Nanae
The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title_full The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title_fullStr The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title_full_unstemmed The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title_short The Prevalence of Dietary Supplement Use for the Purpose of COVID-19 Prevention in Japan
title_sort prevalence of dietary supplement use for the purpose of covid-19 prevention in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370294/
https://www.ncbi.nlm.nih.gov/pubmed/35956391
http://dx.doi.org/10.3390/nu14153215
work_keys_str_mv AT chibatsuyoshi theprevalenceofdietarysupplementuseforthepurposeofcovid19preventioninjapan
AT tanemurananae theprevalenceofdietarysupplementuseforthepurposeofcovid19preventioninjapan
AT chibatsuyoshi prevalenceofdietarysupplementuseforthepurposeofcovid19preventioninjapan
AT tanemurananae prevalenceofdietarysupplementuseforthepurposeofcovid19preventioninjapan